Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 10:04 PM
Study NCT ID:
NCT03760458
Status:
COMPLETED
Last Update Posted:
2023-06-27
First Post:
2018-11-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-29
First Submit QC Date:
None
Study First Post Date:
2018-11-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-09
Results First Submit QC Date:
None
Results First Post Date:
2023-02-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-30
Last Update Post Date:
2023-06-27
Last Update Post Date Type:
ACTUAL